Chairman’s Introduction and Overview New Frontiers in Osteoporosis Evolving Challenges in Fracture Risk Reduction – Boning Up on the Trials, Analyses and What They Mean
Program Chairman and Moderator: Mone Zaidi, MD, PhD, FRCP

Complexities and Challenges of Measuring Fracture End Points – Interpreting the Results of Existing Trials: What Have We Learned?
Steven Harris, MD

The Meaning and Significance of Bone Mineral Density (BMD) as a Biomarker of Fracture Risk and Reduction: Controversies and Challenges
Paul D. Miller, MD

Bone Loss or Lost Bone – The Mandate for Early Treatment of Postmenopausal Osteoporosis: A Research-to-Results Analysis of Triggers and Therapeutic Options
Mone Zaidi, MD, PhD, FRCP

Question and Answer Session
Faculty Panel